Cost-utility analysis of the National Health Screening Program for chronic kidney disease in Korea.
Dun Sol GoSeon-Ha KimJongha ParkDong Ryeol RyuHyeon Jeong LeeMin Woo JoPublished in: Nephrology (Carlton, Vic.) (2019)
The Korean NHSP for CKD is more cost-effective for patients with diabetes or hypertension than the general population, consistent with prior studies. Although it is too early to conclude the cost-effectiveness of the Korean NHSP for CKD, this study provides evidence that is useful in evaluating the cost-effectiveness of CKD interventions.